1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
Global Liquid Biopsy Market - Analysis and Forecast, 2020-2030

Global Liquid Biopsy Market - Analysis and Forecast, 2020-2030

  • September 2020
  • 302 pages
  • ID: 5228682
  • Format: PDF
  • BIS Research


Table of Contents

Global Liquid Biopsy Market to Reach $12.9 Billion by 2030

Market Report Coverage - Global Liquid Biopsy

Market Segmentation

• By Technology: Next-Generation Sequencing, Polymerase Chain Reaction and Other Technologies
• By Workflow: Sample Collection and Preparation, Library Preparation, Sequencing, and Data Analysis and Management
• By Usage: Research, Clinical
• By Sample:Blood, Urine, Saliva, and Cerebrospinal Fluid
• By Circulating Biomarker: Circulating Tumor Cells,Cell-free DNA,Circulating Cell-Free RNA,Exosomes and Extracellular Vesicles,and Others
• By Products: Tests/Services, Kits and Consumables, and Instruments
• By Indication: Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Melanoma, Other Cancers, and Non-Oncology Disorders
• By Clinical Application:Treatment Monitoring,Prognosis and Recurrence Monitoring, Treatment Selection, and Diagnosis and Screening
• By Region: North America, Europe, Asia-Pacific,Latin America and Middle East, and Rest-of-the-World

Regional Segmentation

• North America – U.S., Canada
• Europe – Germany, France, U.K., Italy, Spain, Rest-of-Europe
• Asia-Pacific – China, Japan, India, Australia, South Korea, Singapore, Rest-of-Asia-Pacific
• Latin America and Middle East– Brazil, Mexico, Saudi Arabia, Rest-of-Latin America and Middle East
• Rest-of-the-World

Growth Drivers

• Rising Prevalence of Cancers
• Increasing Adoption of Inorganic Growth Strategies in the Market
• Increased NCI funding

Market Challenges

• False Negatives and Positives
• Uncertain Reimbursement and Regulatory Scenario
• Existing Diagnostic Confidence on Standard Tumor Biopsies
• Expected Implementation of Patient Protection and Affordable Care Act

Market Opportunities

• Potential Cost Savings
• Existing Applicability in Non-Availability of Tissue Sections for Traditional Biopsy Approaches
• Entry of Major Players in the Organ Transplantation Liquid Biopsy Segment

Key Companies Profiled

GUARDANT HEALTH, Biocept, Bio-Rad Laboratories, Cynvenio Biosystems, Chronix Biomedical,Illumina ,and Neogenomics Laboratories, among others.

Key Questions Answered in this Report:
• What are liquid biopsies? How different settings for liquid biopsieshave evolvedover the centuries?
• What are the major market drivers, challenges, and opportunities in the global liquid biopsymarket?
• What was the global liquid biopsy market size in terms of revenue in 2019? How is the market expected to evolve in during the forecast period, 2020-2030? What is the expected market size in 2030?
• How is each segment of the global liquid biopsy market expected to grow during the forecast period between 2020 to 2030,and what revenue is expected to be generated by each of the segments by the end of 2030?
• What are the developmental strategies implemented by the key players to sustain in the competitive market?
• What is the growth potential of the global liquid biopsyin different countries?
• Which service segments among oncology and non-oncology are offered by the key players such asGUARDANT HEALTH, INIVATA, and FOUNDATION MEDICINE?
• Which liquid biopsy segment led the market in 2019?Which segment is expected to dominate the market by2030, and why?
• Which application type led the market in 2019?Which segment is expected to dominate the market by2030, and why?
• Which region dominated the global liquid biopsy market in 2019, and what are the expected trends from each region overthe forecast period 2020-2030?

Market Overview

Liquid biopsy is anon-invasive clinical alternative to surgical tissue biopsies. Performing liquid biopsies enables physicians to discover a wider range of information about tumors through the assessment of blood or other fluid-basedsamples from a perspective cancer patient.

Traditionally, the liquid biopsy services were mainly focused on oncology settings, such as treatment decisions, recurrence monitoring, and screening.However, with the advent of new players in the liquid biopsy market, transplant rejection assessment services and infectious disease services based on liquid biopsies areset to become eminent parts of current practices.

Several players, such as GUARDANT HEALTH, CareDX, and Chronix Biomedical,currently offer these services in the market. The entry of new players in the market, coupled up with the increased innovation pertaining to cost mitigation and resource output maximization,has been transforming the market currently.

The existing market of liquid biopsy is favored by multiple factors, includingrising prevalence of cancers, increasing adoption of inorganic growth strategies in the market, and increased NCI funding.

Within the research report, the market is segmented on the basis of technology offered by key players (NGS, PCR, FISH, and other technologies), workflow (sample preparation, library preparation, sequencing, and data analysis), usage (RUO and diagnostic), sample (blood and non-blood samples), circulating biomarker (circulating tumor cells, cell-free DNA, circulating RNA, exosomes and extracellular vesicles, and others), product (test/services, kits and consumables, and instruments), oncology indication type (lung cancer, breast cancer, prostate cancer, colorectal cancer, melanoma, and other cancers), clinical application (treatment monitoring, prognosis and recurrence monitoring, treatment selection, diagnosis, and screening), and region (North America, Europe, Latin America and Middle East, and Asia-Pacific).This segmentation highlights value propositions and business models useful for industry leaders and stakeholders.

The research also comprises country-level analysis, go-to-market strategies of leading players, future opportunities, among others, to detail the scope and provide a 360° coverage of the domain.

Competitive Landscape

Major players, including GUARDANT HEALTH, Biocept, Bio-Rad Laboratories, and Cynvenio Biosystems, among others, led the number of synergistic developments (partnerships and alliances) witnessed inthe market.On the basis of region, North America is expected to retain a leading position throughout the forecast period 2020-2030, followed byEurope.

The high growth is attributed to the presence of leading industry players in North America, coupled up with therising prevalenceof cancer.

Countries Covered
• North America
• U.S.
• Canada
• Europe
• Germany
• France
• Italy
• U.K.
• Spain
• Rest-of-Europe
• Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Singapore
• Rest-of-Asia-Pacific
• Latin America and Middle East
• Brazil
• Mexico
• Saudi Arabia
• Rest-of-the-World

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

In-Vitro Fertilization Market Research Report by Instrument, by Technology, by End User, by State - United States Forecast to 2026 - Cumulative Impact of COVID-19

  • $ 4949
  • October 2021
  • 199 pages

In-Vitro Fertilization Market Research Report by Instrument (Cabinet, Incubators, and Micromanipulator), by Technology (Intra-cytoplasmic Sperm Injection and Preimplantation Genetic Diagnosis), by End ...

  • United States
  • Diagnostics
  • Genetic Testing
  • Industry analysis


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on